Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease

• Autor(a) principal: Naylor, Ross
• Data de Publicação: 2023
• Outros Autores: Rantner, Barbara, Ancetti, Stefano, de Borst, Gert J., De Carlo, Marco, Halliday, Alison, Kakkos, Stavros K., Markus, Hugh S., McCabe, Dominick J.H., Sillesen, Henrik, van den Berg, Jos C., Vega de Ceniga, Melina, Venermo, Maarit A., Vermassen, Frank E.G., ESVS Guidelines Committee, Guidelines Committee, Antoniou, George A., Bastos Goncalves, Frederico, Bjorck, Martin, Chakfe, Nabil, Coscas, Raphael, Dias, Nuno V., Dick, Florian, Hinchliffe, Robert J., Kolh, Philippe, Koncar, Igor B., Lindholt, Jes S., Mees, Barend M.E., Resch, Timothy A., Trimarchi, Santi, Tulamo, Riikka, Twine, Christopher P., Wanhainen, Anders, Document Reviewers, Reviewers, Bellmunt-Montoya, Sergi, Bulbulia, Richard, Darling, R. Clement, Eckstein, Hans Henning, Giannoukas, Athanasios, Koelemay, Mark J.W., Lindström, David, Schermerhorn, Marc, Stone, David H.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10362/163844
• topic: Surgery; Cardiology and Cardiovascular Medicine

Funding Information: Guideline Writing Committee (GWC) members were selected by the GWC chairs and ESVS Guidelines Committee (GC) chair to represent clinicians involved in decision making in patients with atherosclerotic carotid and VA disease. The GWC comprised vascular surgeons, stroke physicians/neurologists, interventional radiologists, and interventional cardiologists (see Appendix B for specialty and institution). Views and preferences for the target population were not sought directly, but Mr Chris Macey of the Irish Heart Foundation and the Stroke Alliance for Europe collaborated in preparing section 14 (Information for Patients). GWC members provided disclosure statements regarding relationships that could be perceived as conflicts of interest (these are filed and available at ESVS headquarters via [e-mail] ). GWC members received no financial support from any pharmaceutical, device, or industry body, to develop the guidelines.